FFCP PHASE1:Mm9::chr11:120800350..120800383,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr11:120800350..120800383,+|id=chr11:120800350..120800383,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,4.50e-13,9;CL:0002476,2.35e-07,2|ontology_enrichment_disease=DOID:0060100!1.92e-15!3;DOID:4045!1.92e-15!3;DOID:0050686!5.78e-08!6|ontology_enrichment_disease_v019_2=DOID:0060100,1.58e-37,3;DOID:4045,1.58e-37,3;DOID:0050686,3.24e-19,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,4.50e-13,9;UBERON:0002036,4.50e-13,9;UBERON:0002385,4.50e-13,9;UBERON:0000486,4.50e-13,9;UBERON:0007503,4.50e-13,9;UBERON:0001015,4.50e-13,9;UBERON:0002329,4.50e-13,9;UBERON:0003082,4.50e-13,9;UBERON:0003059,4.50e-13,9;UBERON:0007282,4.50e-13,9;UBERON:0004290,4.50e-13,9;UBERON:0009618,4.50e-13,9;UBERON:0000383,7.70e-12,10;UBERON:0007524,7.91e-11,11;UBERON:0003077,7.91e-11,11;UBERON:0007285,7.91e-11,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221730510655305,0,0,0,0,0,0,5.02237956884289,3.906676722619,5.23523743973798,24.1174910092716,11.6117732442936,9.71020706062307,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117588707135705,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157635144106191,0,0,0,0,0,1.50791283939272,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.412773735926445,0,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117357238645754,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0897138566094757,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220591419119515,0|short_description=p@chr11:120800350..120800383,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr11:120800350..120800383,+ | |||
|description=CAGE_peak_at_chr11:120800350..120800383,+ | |||
|id=chr11:120800350..120800383,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,4.50e-13,9;CL:0002476,2.35e-07,2 | |||
|ontology_enrichment_disease=DOID:0060100!1.92e-15!3;DOID:4045!1.92e-15!3;DOID:0050686!5.78e-08!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.58e-37,3;DOID:4045,1.58e-37,3;DOID:0050686,3.24e-19,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,4.50e-13,9;UBERON:0002036,4.50e-13,9;UBERON:0002385,4.50e-13,9;UBERON:0000486,4.50e-13,9;UBERON:0007503,4.50e-13,9;UBERON:0001015,4.50e-13,9;UBERON:0002329,4.50e-13,9;UBERON:0003082,4.50e-13,9;UBERON:0003059,4.50e-13,9;UBERON:0007282,4.50e-13,9;UBERON:0004290,4.50e-13,9;UBERON:0009618,4.50e-13,9;UBERON:0000383,7.70e-12,10;UBERON:0007524,7.91e-11,11;UBERON:0003077,7.91e-11,11;UBERON:0007285,7.91e-11,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221730510655305,0,0,0,0,0,0,5.02237956884289,3.906676722619,5.23523743973798,24.1174910092716,11.6117732442936,9.71020706062307,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117588707135705,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157635144106191,0,0,0,0,0,1.50791283939272,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.412773735926445,0,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117357238645754,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0897138566094757,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220591419119515,0 | |||
|short_description=p@chr11:120800350..120800383,+ | |||
}} |
Latest revision as of 15:47, 5 August 2015
Short description: | p@chr11:120800350..120800383, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr11:120800350..120800383, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 4.50e-13 | 9 |
bone marrow macrophage | 2.35e-07 | 2 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 4.50e-13 | 9 |
striated muscle tissue | 4.50e-13 | 9 |
muscle tissue | 4.50e-13 | 9 |
multilaminar epithelium | 4.50e-13 | 9 |
epithelial vesicle | 4.50e-13 | 9 |
musculature | 4.50e-13 | 9 |
somite | 4.50e-13 | 9 |
myotome | 4.50e-13 | 9 |
presomitic mesoderm | 4.50e-13 | 9 |
presumptive segmental plate | 4.50e-13 | 9 |
dermomyotome | 4.50e-13 | 9 |
trunk paraxial mesoderm | 4.50e-13 | 9 |
musculature of body | 7.70e-12 | 10 |
dense mesenchyme tissue | 7.91e-11 | 11 |
paraxial mesoderm | 7.91e-11 | 11 |
presumptive paraxial mesoderm | 7.91e-11 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.58e-37 | 3 |
muscle cancer | 1.58e-37 | 3 |
organ system cancer | 3.24e-19 | 6 |